CURRENT TOPICS IN MEDICINAL CHEMISTRY

Scope & Guideline

Advancing the Frontiers of Medicinal Chemistry

Introduction

Immerse yourself in the scholarly insights of CURRENT TOPICS IN MEDICINAL CHEMISTRY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1568-0266
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2001 to 2024
AbbreviationCURR TOP MED CHEM / Curr. Top. Med. Chem.
Frequency32 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

CURRENT TOPICS IN MEDICINAL CHEMISTRY focuses on the latest advancements in medicinal chemistry, emphasizing the synthesis, design, and application of pharmacologically active compounds. This journal serves as a platform for researchers to share innovative methodologies and findings that contribute to the understanding and development of new therapeutic agents.
  1. Synthesis of Bioactive Compounds:
    The journal covers research focused on the development and synthesis of novel bioactive compounds, including small molecules, natural products, and hybrid structures that hold therapeutic potential.
  2. Drug Discovery and Development:
    Emphasizing the drug discovery process, the journal includes studies that explore the mechanisms of action, efficacy, and safety profiles of new and existing compounds against various diseases.
  3. Computational and Structural Biology:
    There is a strong emphasis on computational approaches, such as molecular docking and QSAR modeling, to predict the efficacy of drug candidates and to understand their interactions at the molecular level.
  4. Pharmacology and Therapeutics:
    Research published in the journal often includes pharmacological studies that investigate the therapeutic effects of compounds, their mechanisms of action, and potential clinical applications.
  5. Natural Products and Traditional Medicine:
    The journal frequently highlights studies on natural products derived from plants and other organisms, exploring their pharmacological properties and potential as alternatives to conventional therapies.
  6. Multitarget Drug Approaches:
    A notable focus is placed on the development of multitarget drugs that can address complex diseases such as cancer and neurodegenerative disorders, enhancing therapeutic efficacy and reducing side effects.
CURRENT TOPICS IN MEDICINAL CHEMISTRY has been at the forefront of several emerging research trends that reflect the evolving landscape of drug discovery and development. The following themes have gained significant traction in recent publications, indicating a shift towards innovative approaches and interdisciplinary research.
  1. Nanotechnology in Drug Delivery:
    Research on nanotechnology applications in drug delivery systems is rapidly increasing, highlighting the potential of nanocarriers to enhance the bioavailability and efficacy of therapeutic agents.
  2. Artificial Intelligence in Drug Discovery:
    The integration of artificial intelligence and machine learning techniques in drug discovery processes is becoming a prominent theme, offering new avenues for compound design, optimization, and predictive modeling.
  3. Immunotherapy and Targeted Therapies:
    There is a growing interest in immunotherapeutic strategies and targeted therapies, particularly in oncology, where researchers are exploring ways to enhance the immune response against tumors.
  4. Natural Products as Drug Candidates:
    The resurgence of interest in natural products and phytochemicals as potential drug candidates is evident, with a focus on their multifaceted biological activities and mechanisms of action.
  5. Microbiome and Drug Interactions:
    Research exploring the interaction between the microbiome and pharmacotherapy is emerging, emphasizing the importance of understanding how gut microbiota can influence drug metabolism and efficacy.
  6. Sustainable and Green Chemistry Practices:
    The journal is increasingly featuring studies on sustainable and environmentally friendly synthetic methodologies, reflecting a broader commitment to reducing the ecological impact of drug development.

Declining or Waning

While CURRENT TOPICS IN MEDICINAL CHEMISTRY maintains a diverse array of research themes, certain areas have shown a decline in publication frequency or emphasis over the years. These waning scopes reflect shifts in research priorities and emerging trends in medicinal chemistry.
  1. Traditional Antibacterial Agents:
    Research focusing solely on conventional antibacterial agents has decreased, likely due to the rising interest in novel antimicrobial strategies, including the use of natural products and hybrid compounds.
  2. Single-target Drug Design:
    There is a noticeable decline in studies centered on single-target drug design, as the field shifts towards a more integrated approach that considers multitarget strategies and polypharmacology.
  3. Basic Research on Established Drugs:
    The journal has seen fewer submissions related to the basic pharmacological research of established drugs, which may be overshadowed by the exploration of new compounds and innovative therapeutic approaches.
  4. Chemical Modifications of Well-known Scaffolds:
    The focus on minor chemical modifications of well-characterized scaffolds appears to be waning, as researchers are increasingly interested in discovering new scaffolds with novel mechanisms of action.
  5. Synthetic Methodologies for Known Compounds:
    There has been a reduction in publications dedicated to the synthesis of already well-studied compounds, with a stronger emphasis now on developing new synthetic strategies and methodologies.

Similar Journals

MEDICINAL RESEARCH REVIEWS

Unveiling Insights for Tomorrow’s Health Solutions
Publisher: WILEYISSN: 0198-6325Frequency: 6 issues/year

MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

CURRENT DRUG TARGETS

Navigating the Landscape of Pharmacology
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1389-4501Frequency: 16 issues/year

CURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.

Current Computer-Aided Drug Design

Fostering Collaboration for Breakthroughs in Drug Discovery
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4099Frequency: 4 issues/year

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Shaping Therapeutic Strategies with High-Quality Research.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0223-5234Frequency: 18 issues/year

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

Future Medicinal Chemistry

Shaping the future of pharmacology and molecular medicine.
Publisher: Newlands Press LtdISSN: 1756-8919Frequency: 24 issues/year

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

Chemical Biology & Drug Design

Transforming research into real-world health solutions.
Publisher: WILEYISSN: 1747-0277Frequency: 12 issues/year

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Exploring breakthroughs in bioorganic science.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-894XFrequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Advancing Medicinal Chemistry for Tomorrow
Publisher: TAYLOR & FRANCIS LTDISSN: 1475-6366Frequency: 1 issue/year

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

Iranian Journal of Pharmaceutical Research

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: BRIEFLANDISSN: 1735-0328Frequency: 4 issues/year

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego

Fostering Collaboration for a Healthier Tomorrow
Publisher: MEDICAL UNIV WARSAWISSN: 2080-1602Frequency:

Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego is a prestigious academic journal dedicated to publishing high-quality research in the field of pharmaceutical sciences. Published by the Medical University of Warsaw, this journal serves as a vital platform for researchers, professionals, and students to share their findings and advances in drug development, pharmaceutical sciences, and clinical practices. With its ISSN 2080-1602, it upholds rigorous standards of academic integrity and relevance to the pharmaceutical community. Although it currently does not offer open access, the journal plays a crucial role in disseminating knowledge, contributing to the advancement of pharmacy and health sciences. Located in Warsaw, Poland, it aims to bridge gaps in pharmaceutical research and practice, fostering collaboration and innovation among professionals in the field.